1 RNA-based Biopharmaceuticals Market Overview
1.1 Product Overview and Scope of RNA-based Biopharmaceuticals
1.2 RNA-based Biopharmaceuticals Segment by Type
1.2.1 Global RNA-based Biopharmaceuticals Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Therapeutics
1.2.3 Vaccines
1.3 RNA-based Biopharmaceuticals Segment by Application
1.3.1 Global RNA-based Biopharmaceuticals Sales Comparison by Application: (2023-2030)
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Global RNA-based Biopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global RNA-based Biopharmaceuticals Revenue 2018-2030
1.4.2 Global RNA-based Biopharmaceuticals Sales 2018-2030
1.4.3 RNA-based Biopharmaceuticals Market Size by Region: 2018 Versus 2022 Versus 2030
2 RNA-based Biopharmaceuticals Market Competition by Manufacturers
2.1 Global RNA-based Biopharmaceuticals Sales Market Share by Manufacturers (2018-2023)
2.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Manufacturers (2018-2023)
2.3 Global RNA-based Biopharmaceuticals Average Price by Manufacturers (2018-2023)
2.4 Manufacturers RNA-based Biopharmaceuticals Manufacturing Sites, Area Served, Product Type
2.5 RNA-based Biopharmaceuticals Market Competitive Situation and Trends
2.5.1 RNA-based Biopharmaceuticals Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest RNA-based Biopharmaceuticals Players Market Share by Revenue
2.5.3 Global RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 RNA-based Biopharmaceuticals Retrospective Market Scenario by Region
3.1 Global RNA-based Biopharmaceuticals Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global RNA-based Biopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America RNA-based Biopharmaceuticals Market Facts & Figures by Country
3.3.1 North America RNA-based Biopharmaceuticals Sales by Country
3.3.2 North America RNA-based Biopharmaceuticals Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe RNA-based Biopharmaceuticals Market Facts & Figures by Country
3.4.1 Europe RNA-based Biopharmaceuticals Sales by Country
3.4.2 Europe RNA-based Biopharmaceuticals Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific RNA-based Biopharmaceuticals Market Facts & Figures by Region
3.5.1 Asia Pacific RNA-based Biopharmaceuticals Sales by Region
3.5.2 Asia Pacific RNA-based Biopharmaceuticals Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America RNA-based Biopharmaceuticals Market Facts & Figures by Country
3.6.1 Latin America RNA-based Biopharmaceuticals Sales by Country
3.6.2 Latin America RNA-based Biopharmaceuticals Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa RNA-based Biopharmaceuticals Market Facts & Figures by Country
3.7.1 Middle East and Africa RNA-based Biopharmaceuticals Sales by Country
3.7.2 Middle East and Africa RNA-based Biopharmaceuticals Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global RNA-based Biopharmaceuticals Historic Market Analysis by Type
4.1 Global RNA-based Biopharmaceuticals Sales Market Share by Type (2018-2023)
4.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Type (2018-2023)
4.3 Global RNA-based Biopharmaceuticals Price by Type (2018-2023)
5 Global RNA-based Biopharmaceuticals Historic Market Analysis by Application
5.1 Global RNA-based Biopharmaceuticals Sales Market Share by Application (2018-2023)
5.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Application (2018-2023)
5.3 Global RNA-based Biopharmaceuticals Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer RNA-based Biopharmaceuticals Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Roche RNA-based Biopharmaceuticals Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Sanofi-Aventis
6.3.1 Sanofi-Aventis Corporation Information
6.3.2 Sanofi-Aventis Description and Business Overview
6.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi-Aventis RNA-based Biopharmaceuticals Product Portfolio
6.3.5 Sanofi-Aventis Recent Developments/Updates
6.4 Abbott Laboratories
6.4.1 Abbott Laboratories Corporation Information
6.4.2 Abbott Laboratories Description and Business Overview
6.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Abbott Laboratories RNA-based Biopharmaceuticals Product Portfolio
6.4.5 Abbott Laboratories Recent Developments/Updates
6.5 Arrowhead Pharmaceuticals
6.5.1 Arrowhead Pharmaceuticals Corporation Information
6.5.2 Arrowhead Pharmaceuticals Description and Business Overview
6.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product Portfolio
6.5.5 Arrowhead Pharmaceuticals Recent Developments/Updates
6.6 Benitec Biopharma
6.6.1 Benitec Biopharma Corporation Information
6.6.2 Benitec Biopharma Description and Business Overview
6.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Benitec Biopharma RNA-based Biopharmaceuticals Product Portfolio
6.6.5 Benitec Biopharma Recent Developments/Updates
6.7 Calimmune Inc
6.6.1 Calimmune Inc Corporation Information
6.6.2 Calimmune Inc Description and Business Overview
6.6.3 Calimmune Inc RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Calimmune Inc RNA-based Biopharmaceuticals Product Portfolio
6.7.5 Calimmune Inc Recent Developments/Updates
6.8 Dicerna
6.8.1 Dicerna Corporation Information
6.8.2 Dicerna Description and Business Overview
6.8.3 Dicerna RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Dicerna RNA-based Biopharmaceuticals Product Portfolio
6.8.5 Dicerna Recent Developments/Updates
6.9 Gradalis
6.9.1 Gradalis Corporation Information
6.9.2 Gradalis Description and Business Overview
6.9.3 Gradalis RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Gradalis RNA-based Biopharmaceuticals Product Portfolio
6.9.5 Gradalis Recent Developments/Updates
6.10 Quark
6.10.1 Quark Corporation Information
6.10.2 Quark Description and Business Overview
6.10.3 Quark RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Quark RNA-based Biopharmaceuticals Product Portfolio
6.10.5 Quark Recent Developments/Updates
6.11 RXi
6.11.1 RXi Corporation Information
6.11.2 RXi RNA-based Biopharmaceuticals Description and Business Overview
6.11.3 RXi RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.11.4 RXi RNA-based Biopharmaceuticals Product Portfolio
6.11.5 RXi Recent Developments/Updates
6.12 Senesco
6.12.1 Senesco Corporation Information
6.12.2 Senesco RNA-based Biopharmaceuticals Description and Business Overview
6.12.3 Senesco RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Senesco RNA-based Biopharmaceuticals Product Portfolio
6.12.5 Senesco Recent Developments/Updates
6.13 Silence Therapeutics
6.13.1 Silence Therapeutics Corporation Information
6.13.2 Silence Therapeutics RNA-based Biopharmaceuticals Description and Business Overview
6.13.3 Silence Therapeutics RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Silence Therapeutics RNA-based Biopharmaceuticals Product Portfolio
6.13.5 Silence Therapeutics Recent Developments/Updates
6.14 Silenseed
6.14.1 Silenseed Corporation Information
6.14.2 Silenseed RNA-based Biopharmaceuticals Description and Business Overview
6.14.3 Silenseed RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Silenseed RNA-based Biopharmaceuticals Product Portfolio
6.14.5 Silenseed Recent Developments/Updates
6.15 Tekmira
6.15.1 Tekmira Corporation Information
6.15.2 Tekmira RNA-based Biopharmaceuticals Description and Business Overview
6.15.3 Tekmira RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Tekmira RNA-based Biopharmaceuticals Product Portfolio
6.15.5 Tekmira Recent Developments/Updates
6.16 Alnylam Pharmaceuticals
6.16.1 Alnylam Pharmaceuticals Corporation Information
6.16.2 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Description and Business Overview
6.16.3 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product Portfolio
6.16.5 Alnylam Pharmaceuticals Recent Developments/Updates
7 RNA-based Biopharmaceuticals Manufacturing Cost Analysis
7.1 RNA-based Biopharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of RNA-based Biopharmaceuticals
7.4 RNA-based Biopharmaceuticals Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 RNA-based Biopharmaceuticals Distributors List
8.3 RNA-based Biopharmaceuticals Customers
9 RNA-based Biopharmaceuticals Market Dynamics
9.1 RNA-based Biopharmaceuticals Industry Trends
9.2 RNA-based Biopharmaceuticals Market Drivers
9.3 RNA-based Biopharmaceuticals Market Challenges
9.4 RNA-based Biopharmaceuticals Market Restraints
10 Global Market Forecast
10.1 RNA-based Biopharmaceuticals Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of RNA-based Biopharmaceuticals by Type (2023-2030)
10.1.2 Global Forecasted Revenue of RNA-based Biopharmaceuticals by Type (2023-2030)
10.2 RNA-based Biopharmaceuticals Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of RNA-based Biopharmaceuticals by Application (2023-2030)
10.2.2 Global Forecasted Revenue of RNA-based Biopharmaceuticals by Application (2023-2030)
10.3 RNA-based Biopharmaceuticals Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of RNA-based Biopharmaceuticals by Region (2023-2030)
10.3.2 Global Forecasted Revenue of RNA-based Biopharmaceuticals by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
